Share Prices & Company Research

Market News

07 May 2020 | 12:34

Berenberg raises target price on Smith and Nephew

(Sharecast News) - Analysts at Berenberg upped their target price on medical equipment manufacturer Smith & Nephew from ?21.35 to ?21.65 on Thursday, stating the group's outlook was beginning to improve. Berenberg highlighted that Smith & Nephew's revenues were down 47% on an underlying basis in April but the analysts said with "a gradual resumption" of elective surgery looking imminent, they think that drop will mark the low and that a return to near-normal levels of business activity in 2021 looked "increasingly likely".

Thereafter, the German bank expects the company to pick up where it left off and deliver sustained, above-market revenue growth, expand margins and improve earnings growth.

"We expect an 11% 2021-2025E EPS CAGR. With the shares at 18.8x our 2021E adjusted EPS, they are not, in our view, pricing in this earnings growth outlook," said Berenberg, which also reiterated its 'buy' rating on S&N.

Berenberg also stated that the increase in its DCF-derived price target related to the "slight recent strengthening" of the US dollar.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 15th January 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.